Company context
The public record describes A28 Therapeutics as Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.. Its recorded founding year is 2021.
- Public business description
- Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.
- Country in source record
- United States
- Founding year in source record
- 2021
Recorded founders
- Stanley T. Lewis · American physician and biotechnology entrepreneur, founder of A28 Therapeutics
The linked people are recorded under the company’s founder property in the cited dataset. This is a founding association, rather than a verification of current equity or management responsibility.
More from the public record
These details describe the cited record as reviewed on October 9, 2026. They may describe an earlier period; they are not a current employment or operating-status check.
- Recorded official name
- A28 Therapeutics Inc · View source field
Understanding A28 Therapeutics in context
A28 Therapeutics is included because its public company record connects a named business to an identifiable founding team. The business description, “Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.,” supplies the context for that relationship, with a recorded starting year of 2021. The founding association shown here is with Stanley T. Lewis. A single association in this library should not be read as a complete list of everyone who helped establish the business.
The company website listed in the source is the next place to research its current offering. Compare the company’s own description, its leadership information, and dated announcements with this reference record before drawing conclusions about today’s business. A founding year describes a historical event; it does not measure business scale, growth, or the length of a founder’s continuing involvement.
Research context: Health and life sciences businesses
A health-company description may concern research, a development-stage product, a service business, or commercial distribution. Those stages have different meanings. A founding association is not evidence of clinical results, regulatory authorization, or the availability of a product. Use dated primary company materials and the appropriate official records when evaluating such claims.
Questions for researching A28 Therapeutics
- What does the company currently identify as its stage of development or service scope?
- Are product availability and research milestones presented with dates and primary sources?
- Does a biography distinguish scientific, executive, advisory, and founding roles?
This sector context is a reading guide based on the company’s recorded description. It does not attribute a particular business model or capability to A28 Therapeutics without supporting evidence.
This reference library documents public founding associations. It is separate from our revenue-qualified growth profiles. Founding does not establish current ownership, employment, company revenue, or an AE client relationship.
Research trail
- Wikidata public record Q139829650: company description, country, founding year where present, and founder associations.
- A28 Therapeutics website as listed in the public record
- Supporting reference linked from the founder statement
Following up with the business
For current products, services, management, and availability, consult the business directly. Revenue and current ownership have not been independently verified for this reference record. Authorized representatives can submit a correction with a current company biography, filing, or other public evidence.